肢端肥大症患者肿瘤大小、年龄、血浆生长激素与鞍外扩展发生率之间的相互关系。 - Suppr

Suppr

超能文献

Interrelationships between tumour size, age, plasma growth hormone and incidence of extrasellar extension in acromegalic patients.

作者信息

Klijn J G, Lamberts S W, de Jong F H, van Dongen K J, Birkenhäger J C

出版信息

Acta Endocrinol (Copenh). 1980 Nov;95(3):289-97. doi: 10.1530/acta.0.0950289.

DOI:10.1530/acta.0.0950289

PMID:7435120

Abstract

摘要

相似文献

Interrelationships between tumour size, age, plasma growth hormone and incidence of extrasellar extension in acromegalic patients.肢端肥大症患者肿瘤大小、年龄、血浆生长激素与鞍外扩展发生率之间的相互关系。

Acta Endocrinol (Copenh). 1980 Nov;95(3):289-97. doi: 10.1530/acta.0.0950289.

Prolactin secretion and synthesis in short- and long-term organ culture of pituitary tumours from acromegalic patients.肢端肥大症患者垂体肿瘤短期和长期器官培养中的催乳素分泌与合成

Acta Endocrinol (Copenh). 1978 Apr;87(4):701-15. doi: 10.1530/acta.0.0870701.

Serum growth hormone levels and size of pituitary tumour in untreated acromegaly.未经治疗的肢端肥大症患者的血清生长激素水平与垂体瘤大小

Br Med J. 1969 Dec 6;4(5683):582-4. doi: 10.1136/bmj.4.5683.582.

Plasma growth hormone response to growth hormone-releasing factor in acromegalic patients.肢端肥大症患者血浆生长激素对生长激素释放因子的反应。

J Clin Endocrinol Metab. 1984 Jan;58(1):215-7. doi: 10.1210/jcem-58-1-215.

Invasive pituitary tumor producing acromegaly, extreme elevation of growth hormone, and abnormal growth in tissue culture.侵袭性垂体瘤导致肢端肥大症、生长激素极度升高以及组织培养中的异常生长。

Neurochirurgia (Stuttg). 1974 Jul;17(4):129-35. doi: 10.1055/s-0028-1090474.

[Levels of growth hormone and prolactin in the blood before, during, and after selective transsphenoidal adenectomy in patients with acromegaly and hypophyseal prolactin-producing tumors].[肢端肥大症和垂体泌乳素瘤患者选择性经蝶窦腺瘤切除术前、术中和术后血液中生长激素和泌乳素水平]

Acta Med Iugosl. 1987;41(4):229-44.

Effect of dihydroergocristine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic, and acromegalic subjects: further evidence for pituitary dopamine deficiency in these conditions.双氢麦角汀给药对正常、高催乳素血症及肢端肥大症患者血清催乳素和生长激素水平的影响：这些病症中垂体多巴胺缺乏的进一步证据

Acta Endocrinol (Copenh). 1983 May;103(1):1-6. doi: 10.1530/acta.0.1030001.

Evidence of a circulating growth hormone stimulating factor other than growth hormone releasing hormone in a patient with pituitary tumour and acromegaly.一名垂体瘤和肢端肥大症患者体内存在除生长激素释放激素外的循环生长激素刺激因子的证据。

Acta Endocrinol (Copenh). 1985 Jul;109(3):289-94. doi: 10.1530/acta.0.1090289.

Another case where bigger is not better.

Cardiovasc Res. 1997 Oct;36(1):1-2. doi: 10.1016/s0008-6363(97)00136-3.

Acromegaly and galactorrhea-amenorrhea with two pituitary adenomas secreting growth hormone or prolactin. A case report.肢端肥大症合并溢乳-闭经伴两个分泌生长激素或催乳素的垂体腺瘤。病例报告。

Ann Intern Med. 1978 Sep;89(3):345-8. doi: 10.7326/0003-4819-89-3-345.

引用本文的文献

From Subtle Signs to Severe Sequelae-A Century of Symptomatology and Comorbidities in the Diagnosis of GH-Secreting Pituitary Neuroendocrine Tumors: A Systematic Review.从细微迹象到严重后遗症——生长激素分泌型垂体神经内分泌肿瘤诊断中的一个世纪症状学与合并症：一项系统综述

Diagnostics (Basel). 2025 Aug 24;15(17):2137. doi: 10.3390/diagnostics15172137.

Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines.肢端肥大症诊断时的临床体征、症状和合并症的流行情况：按照 PRISMA 指南进行的系统评价。

Pituitary. 2023 Aug;26(4):319-332. doi: 10.1007/s11102-023-01322-7. Epub 2023 May 20.

Absence of immunostaining for growth hormone in a subset of patients with acromegaly.生长激素在一部分肢端肥大症患者中免疫染色缺失。

Pituitary. 2014 Apr;17(2):103-8. doi: 10.1007/s11102-013-0474-4.

Medical therapy of acromegaly.肢端肥大症的医学治疗。

Int J Endocrinol. 2012;2012:268957. doi: 10.1155/2012/268957. Epub 2012 Apr 10.

Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy.未经放疗和药物治疗的肢端肥大症患者中培维索孟和长效奥曲肽的比较。

J Endocrinol Invest. 2009 Dec;32(11):924-33. doi: 10.1007/BF03345774. Epub 2009 Dec 4.

Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed.324 例肢端肥大症患者的诊断特征从 1981 年到 2006 年没有变化：肢端肥大症仍然未被充分认识和诊断。

Clin Endocrinol (Oxf). 2010 Feb;72(2):203-8. doi: 10.1111/j.1365-2265.2009.03626.x. Epub 2009 May 16.

Epidemiology of acromegaly.肢端肥大症的流行病学

Pituitary. 1999 Jun;2(1):29-41. doi: 10.1023/a:1009965803750.

Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors : comparison between micro- and macroadenomas.促肾上腺皮质激素分泌型垂体瘤增殖和凋亡指数的测定：微腺瘤与大腺瘤的比较

Am J Pathol. 2000 Jan;156(1):245-51. doi: 10.1016/S0002-9440(10)64725-6.

A risk-benefit assessment of octreotide in the treatment of acromegaly.奥曲肽治疗肢端肥大症的风险效益评估。

Drug Saf. 1997 Nov;17(5):317-24. doi: 10.2165/00002018-199717050-00004.

Acromegaly: an epidemiological study.肢端肥大症：一项流行病学研究。

J Endocrinol Invest. 1993 Mar;16(3):181-7. doi: 10.1007/BF03344942.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验